Iright
BRAND / VENDOR: Biolegend

Biolegend, 102102, Purified anti-mouse CD28 Antibody, 500μg

CATALOG NUMBER: 102102
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

CD28 is a 44 kD glycoprotein, also known as Tp44 or T44. It is a member of the Ig superfamily, expressed on thymocytes, most peripheral T cells, and NK cells. In association with CD80 (B7-1) and CD86 (B7-2), CD28 acts as the second signal for T and NK cell activation and proliferation. The 37.51 antibody has been reported to augment in vitro T cell proliferation and cytokine production, and promote CTL development.
500μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Syrian Hamster
Immunogen: C57BL/6 mouse T-cell lymphoma EL-4
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography.
Concentration: 0.5 mg/ml
Storage & Handling: The CD28 antibody solution should be stored undiluted between 2°C and 8°C.
Application: FC - Quality tested IP, IHC-F, Costim, Block - Reported in the literature, not verified in house
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Application Notes: Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro costimulation of T and NK cells1, in vitro blocking of allogeneic mixed leukocyte response and inhibition of MHC-unrestricted CTL cytotoxicity3,4, in vitro induction of thymocyte differentiation2,5-9,11, and immunohistochemical staining of acetone-fixed frozen sections. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 102116).
Application References(PubMed link indicates BioLegend citation): Gross JA, et al. 1992. J. Immunol. 149:380. (IP, Costim) Cibotti R, et al. 1997. Immunity 6:245. (Costim) Masten BJ, et al. 1997. Am. J. Respir. Cell Mol. Biol. 16:335. (Block) Nishio M, et al. 1996. J. Immunol. 157:4347. (Block) Zhang N and He Y-W, 2005. J. Exp. Med. 202:395. (Costim) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Costim) Perchonock CE, et al. 2006. Mol Cell Biol. 26(16):6005. (Costim) Wang W, et al. 2007. J. Immunol. 178:4885. (Costim) Pua HH, et al. 2007. J. Exp. Med. 204:25. (Costim) Perchonock CE, et al. 2007. J. Immunol. 179:1768. Barbi J, et al. 2007. Blood 110:2215. Milpied P, et al. 2011. Blood 118:2993. PubMed Cunningham NR, et al. 2011. Int Immunol. 23:693. PubMed Crispin JC, et al. 2012. J. Immunol. 188:3567. PubMed Li CR, et al. 2014. J Immunol. 192:1425. PubMed Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
Product Citations: Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed Akiyama C, et al. 2019. J Immunol. 203:835. PubMed Komuczki J, et al. 2019. Immunity. 50:1289. PubMed Oh H, et al. 2017. Immunity. 47:450. PubMed Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed Robles-Valero J, et al. 2022. Mol Oncol. 16:3533. PubMed Kim H, et al. 2023. Bone Res. 11:17. PubMed Anto NP, et al. 2023. Front Immunol. 14:1126464. PubMed Aydin S, et al. 2023. Nat Commun. 14:3106. PubMed Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed Tian J, et al. 2021. Autophagy. 17:2586. PubMed Collin R, et al. 2020. J Immunol. 205:133. PubMed Campisi L, et al. 2022. Nature. 606:945. PubMed Halin C, et al. 2022. EMBO J. 41:e111528. PubMed Liu W, et al. 2022. Stem Cells Int. 2022:1052166. PubMed Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed Cross EW, et al. 2019. PLoS One. 14:e0211446. PubMed Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed Hawse WF, et al. 2019. J Immunol. 203:2771. PubMed Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed Yamada T, et al. 2019. J Immunol. 202:1088. PubMed Liang J, et al. 2017. Nat Commun. 8:15732. PubMed He N 2005. J Immunol. 174:6967. PubMed Crispin J, et al. 2012. J Immunol. 188:3567. PubMed Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed Busnelli M, et al. 2022. Arterioscler Thromb Vasc Biol. 42:839. PubMed Milpied P, et al. 2011. Blood. 118:2993. PubMed Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed Rasoulouniriana D, et al. 2019. J Clin Invest. 129:4151. PubMed Oghumu S, et al. 2019. J Immunol. 203:789. PubMed Lu SX, et al. 2021. Cell. . PubMed Kitamura T, et al. 2018. Front Immunol. 8:2004. PubMed Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed Macchi C, et al. 2022. iScience. 25:104435. PubMed Marangoni F, et al. 2021. Cell. . PubMed Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed Montes de Oca M, et al. 2020. PLoS Pathog. 16:e1008994. PubMed Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed Rao TN, et al. 2020. J Immunol. 204:2600. PubMed Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed Kölle J, et al. 2022. iScience. 25:104440. PubMed Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed Zhang P, et al. 2022. BMC Med. 20:435. PubMed Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed Rosenberger C, et al. 2008. Proc Natl Acad Sci U S A. 105:2544. PubMed Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed Imani J, et al. 2021. JCI Insight. 6:. PubMed Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed Racioppi L, et al. 2019. Nat Commun. 10:2450. PubMed Miret JJ, et al. 2019. J Immunother Cancer. 7:32. PubMed Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed Sharma M, et al. 2020. Circ Res. 127:335. PubMed Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed Samanta D, et al. 2020. Cell Rep. 108073:32. PubMed Hollmann C, et al. 2016. J Immunol. 197: 3130 - 3141. PubMed Thumkeo D, et al. 2020. Sci Adv. 6:eaay2432. PubMed Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed Li Z, et al. 2021. MBio. 12:e0254221. PubMed Zhang S, et al. 2021. Front Immunol. 12:635076. PubMed Endo Y, et al. 2015. Cell Rep. 12: 1042-1055. PubMed Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed Majchrzak K, et al. 2017. JCI Insight. 2:e90547. PubMed Patterson AR, et al. 2019. J Allergy Clin Immunol. 143:245. PubMed Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed Shiozawa S, et al. 2022. iScience. 25:103537. PubMed Wu Y, et al. 2021. J Clin Invest. 131:. PubMed Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed Schiering C, et al. 2017. Nature. 542:242. PubMed Lee J, et al. 2020. Cells. 9:. PubMed Pan S, et al. 2021. Front Cell Dev Biol. 9:629306. PubMed Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed Kiuchi M, et al. 2021. J Exp Med. 218:. PubMed Guo J, et al. 2020. Cell Mol Immunol. 1222:17. PubMed Rosenberg J, et al. 2020. Cell Systems. 10(5):433-444. PubMed Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed Niven J, et al. 2019. Cell Rep. 28:21. PubMed Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed He N 2005. J Exp Med. 202:395. PubMed Cunningham N, et al. 2011. Int Immunol. 1.439583333. PubMed Nakazawa Y, et al. 2021. Elife. 10:. PubMed He Y, et al. 2021. eLife. 10:00. PubMed Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed Li C, et al. 2014. J Immunol. 192:1425. PubMed Robles-Valero J, et al. 2021. EMBO J. 40:e108125. PubMed Wang W, et al. 2022. Nat Commun. 13:4495. PubMed Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed Plaza-Sirvent C, et al. 2017. Cell Rep. 18(1):12-22. PubMed Grinberg–Bleyer Y, et al. 2017. Cell. 170:1096. PubMed Bessell CA, et al. 2020. JCI Insight. 5:. PubMed Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
RRID: AB_312866 (BioLegend Cat. No. 102101) AB_312867 (BioLegend Cat. No. 102102)
Disclaimer: This product may be used for research purposes only. It is not licensed for resale and may only be used by the buyer. This product may not be used and is not licensed for clinical assays where the results of such assays are provided as a diagnostic service. If a diagnostic or therapeutic use is anticipated then a license must be requested from the University of California. The availability of such diagnostic and therapeutic use license(s) cannot be guaranteed from the University of California.
Structure: Ig superfamily, 44 kD
Distribution: Thymocytes, CD4+, CD8+ peripheral T cells, NK cells
Function: Costimulates T and NK cells
Ligand/Receptor: CD80 (B7-1), CD86 (B7-2)
Cell Type: NK cells, T cells, Thymocytes, Tregs
Biology Area: Costimulatory Molecules, Immunology
Molecular Family: CD Molecules
Antigen References: 1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Lenschow DJ, et al. 1996. Annu. Rev. Immunol. 14:233. 3. Gross JA, et al. 1992. J. Immunol. 149:380.
Gene ID: 12487
UniProt: View information about CD28 on UniProt.org
Clone: 37.51
Regulatory Status: RUO
Other Names: Tp44, T44
Isotype: Syrian Hamster IgG


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924